Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Current Fiscal Year End Date Entity Small Business Entity Shell Company Entity Emerging Growth Company Entity Current Reporting Status Document Period End Date Entity Filer Category Document Fiscal Period Focus Document Fiscal Year Focus Entity Common Stock Shares Outstanding Document Quarterly Report Document Transition Report Entity Interactive Data Current Entity File Number Entity Incorporation State Country Code Entity Tax Identification Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code City Area Code Local Phone Number Security 12b Title Trading Symbol Security Exchange Name Scenario [Axis] PreferredStockMember CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS Current assets: Cash and cash equivalents Accounts receivable, net Inventories Prepaid expenses and other current assets Total current assets [Assets, Current] Property and equipment, net Intangible assets, net Goodwill Right to use assets Deposits and other assets TOTAL ASSETS [Assets] LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable Accrued expenses and other current liabilities Current portion of deferred revenue Current portion of lease obligations Total current liabilities [Liabilities, Current] Senior notes payable, net of discount Deferred revenue, net of current portion Lease obligations, net of current portion Other non-current liabilities TOTAL LIABILITIES [Liabilities] STOCKHOLDERS' EQUITY Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding Common Stock - voting, $0.0001 par value, 150,000,000 shares authorized, 123,044,981 and 104,902,888 shares issued and outstanding Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS' EQUITY TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY [Liabilities and Equity] STOCKHOLDERS' EQUITY Preferred stock, shares par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, shares par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) REVENUES: Product revenue License revenue Total revenues [Revenues] OPERATING EXPENSES: Cost of product revenue (exclusive of amortization expense shown below) Research and development Plasma center operating expenses Amortization of intangible assets Selling, general and administrative Total operating expenses [Operating Expenses] LOSS FROM OPERATIONS [Operating Income (Loss)] OTHER INCOME (EXPENSE): Interest income Interest expense Other expense Other expense, net NET LOSS [Net Income (Loss) Attributable to Parent] BASIC AND DILUTED LOSS PER COMMON SHARE WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic and Diluted CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (Unaudited) Statement [Table] Statement [Line Items] Equity Components [Axis] Common Stock Additional Paid-In Capital Accumulated Deficit Balance, shares [Shares, Issued] Balance, amount Stock-based compensation [Stock-based compensation] Issuance of common stock, net of offering expenses, shares Issuance of common stock, net of offering expenses, amount Exercise of stock options, shares Exercise of stock options, amount Net loss Stock-based compensation Vesting of Restricted Stock Units, net of shares withheld for taxes and retired, shares Vesting of Restricted Stock Units, net of shares withheld for taxes and retired, amount Balance, shares Balance, amount CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Loss on disposal of fixed assets Stock-based compensation Amortization of debt discount Amortization of license revenue Changes in operating assets and liabilities: Accounts receivable Inventories [Increase (Decrease) in Inventories] Prepaid expenses and other current assets [Increase (Decrease) in Prepaid Expense] Deposits and other assets [Increase (Decrease) in Other Operating Assets] Accounts payable [Increase (Decrease) in Accounts Payable] Accrued expenses Other current and non-current liabilities Net cash used in operating activities [Net Cash Provided by (Used in) Operating Activities] CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment [Payments to Acquire Property, Plant, and Equipment] Proceeds from the sale of property and equipment Net cash used in investing activities [Net Cash Provided by (Used in) Investing Activities] CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of common stock, net of offering expenses Proceeds from the exercise of stock options Taxes paid on vested Restricted Stock Units Proceeds from issuance of note payable Payments on finance lease obligations [Payments for Leasing Costs] Net cash provided by financing activities [Net Cash Provided by (Used in) Financing Activities] Net increase in cash and cash equivalents [Cash and Cash Equivalents, Period Increase (Decrease)] Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period ORGANIZATION AND BUSINESS 1. ORGANIZATION AND BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INVENTORIES 3. INVENTORIES INTANGIBLE ASSETS 4. INTANGIBLE ASSETS PROPERTY AND EQUIPMENT 5. PROPERTY AND EQUIPMENT ACCRUED EXPENSES AND OTHER LIABILITIES 6. ACCRUED EXPENSES AND OTHER LIABILITIES DEBT 7. DEBT STOCKHOLDERS' EQUITY 8. STOCKHOLDERS' EQUITY RELATED PARTY TRANSACTIONS 9. RELATED PARTY TRANSACTIONS COMMITMENT AND CONTINGENCIES 10. COMMITMENTS AND CONTINGENCIES SEGMENTS 11. SEGMENTS LEASE OBLIGATIONS 12. LEASE OBLIGATIONS SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION 13. SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION SUBSEQUENT EVENTS 14. SUBSEQUENT EVENTS Basis of presentation Use of estimates Fair value of financial instruments Accounts receivable Receivable [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Impairment of long-lived assets Revenue recognition Cost of product revenue Loss per common share Stock-based compensation Compensation Related Costs, Policy [Policy Text Block] Income Taxes Recent Accounting Pronouncements Schedule of dilutive securities Schedule of inventory Schedule of Intangible assets Intangible asset future aggregate amortization expense Schedule of property and equipment Schedule of Accrued expenses and other current liabilities Summary of notes payable Schedule of assumptions Schedule of option activity Schedule of compensation expense Schedule of stock-based compensation expense Summarized segment financial information Schedule of future minimum lease payments Schedule of supplemental cash flow information Consolidated Entities Axis Plan Name Axis Jefferies LLC [Member] Sale Agreement [Member] Cash and cash equivalents [Cash Equivalents, at Carrying Value] Cumulative loss Working capital Sales of common stock Proceeds from sales of common stock Derivative Instrument Risk Axis Award Type Axis Class Of Warrant Or Right Axis Stock Options [Member] Restricted stock units [Member] Warrants [Member] Potentially dilutive securities Related Party Transaction [Axis] Biotest License Agreement [Member] Five Customers [Member] Three Customers [Member] Goodwill [Goodwill, Gross] Amortization period Account receivables Revenues rate Raw materials Work-in-process Finished goods Total inventories INTANGIBLE ASSETS (Details) Finite Lived Intangible Assets By Major Class Axis Trademark and other intangible rights related to Nabi-HB Right to intermediates Customer contract Cost Accumulated amortization Net Remaining of 2021 2022 2023 2024 Amortization of intangible assets [Amortization] Property Plant And Equipment By Type Axis Manufacturing and laboratory equipment [Member] Office equipment and computer software [Member] Furniture and fixtures [Member] Construction in process [Member] Leasehold improvements [Member] Land [Member] Buildings and building improvements [Member] Property, plant and equipments, gross Less: accumulated depreciation [Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment] Total Property, plant and equipments, net Range [Axis] Minimum [Member] Maximum [Member] Depreciation expense Estimated useful life Accrued rebates Accrued distribution fees Accrued payroll Accrued testing Accrued incentives Other Total accrued expenses and other current liabilities Notes payable Less: debt discount Senior notes payable Perceptive Credit Agreement [Member] Effective interest rate Security notes payable Interest paid Interest rate description Additional description Dividend yield Volatility Expected term Risk-free interest rate Share Repurchase Program Axis Shares [Member] Weighted Average Exercise Price [Member] Shares, Outstanding at beginning of period Shares, Forfeited Shares, Expired Shares, Granted Shares, Exercised Shares, Outstanding at end of period and expected to vest [Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number] Shares, Options exercisable [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number] Weighted average exercise price, Beginning of period [Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price] Weighted average exercise price, Forfeited Weighted average exercise price, Expired Weighted average exercise price, Granted Weighted average exercise price, Exercised Weighted average exercise price, Outstanding at end of period and expected to vest Weighted average exercise price, Options exercisable [Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price] Weighted Average Grant Date Fair Value [Member] Weighted average grant date fair value, beginning Weighted average grant date fair value, Granted Weighted average grant date fair value, Vested Weighted average grant date fair value, Forfeited Weighted Average Exercise Price at Ending Balance [Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price] Outstanding at beginning of period Granted Vested Forfeited Outstanding at end of period Income Statement Location Axis Concentration Risk By Benchmark Axis Research and Development [Member] Plasma Center Operating Expenses [Member] Selling, General and Administrative [Member] Cost of goods sold [Member] Total stock-based compensation expense Sale Agreement [Member] Equity Incentive Plans [Member] Preferred stock, par value Preferred stock, outstanding Preferred stock, shares authorized [Preferred Stock, Capital Shares Reserved for Future Issuance] Common stock, par value Common stock, shares issued Common stock, shares authorized Common stock, shares outstanding Underwritten public offering Proceeds from issuance of shares Net proceeds from the issuance of common stock Common stock issuable Shares, Granted Warrants outstanding Weighted average exercise price of warrants Potentially dilutive securities Warrant exercise price per share Common stock issuable under agreement Net proceeds Common stock shares sold during the period Unrecognized compensation expense recognition period Description maximum number of shares reserved for grant Weighted average remaining contractual life of stock options outstanding Unrecognized compensation expense Stock-based compensation expense Compensation expense Related Party Transactions By Related Party Axis Areth, LLC [Member] Credit facility Public offering description Rent expense Plasma supply agreement term Purchase of raw material Purchase percentage from inventory Statement Business Segments Axis ADMA BioManufacturing Plasma Collection Centers Corporate Consolidated (member) Revenues Cost of product revenue Loss from operations Interest and other expense, net Capital expenditure Depreciation and amortization expense TOTAL ASSETS Remainder of 2021 2022 [Operating Leases, Future Minimum Payments, Due in Two Years] 2023 [Operating Leases, Future Minimum Payments, Due in Three Years] 2024 [Operating Leases, Future Minimum Payments, Due in Four Years] 2025 2026 Thereafter Total payments Less: imputed interest [Less: imputed interest] Current portion [Operating Lease, Liability, Current] Total [Total] Lease and rent expense Operating Lease liabilities Weighted average remaining term Right to use assets and corresponding lease liabilities Incremental borrowing rate Cash payments for lease SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for interest Noncash Financing and Inesting Activities: Equipment acquired reflected in accounts payable and accrued liabilities Right-to-use assets in exchange for lease obligations Subsequent Event Type Axis Jefferies LLC [Member] Subsequent Event [Member] Proceeds from issuance of common stock Remaining gross balance that can be raised Common stock shares sold during the period Amount of lease obligation due within one year or the normal operating cycle, if longer. The portion of a bond liability that will not be paid within the upcoming year is classified as a noncurrent liability. Remaining amortization period of deferred revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Number of options outstanding, including both vested and non-vested options. The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Number of options vested. Weighted average grant-date fair value of non-vested options forfeited. Cash received on stock transaction after deduction of issuance costs. The total amount of proceeds received for the sale of securities, categorized neither as held-to-maturity nor trading securities, during the reporting period. Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Amount of increase in right-of-use asset obtained in exchange for operating lease liability. Amount of minimum lease payments for capital leases due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.